TY  - JOUR
AU  - Sadyrbaeva-Dolgova, Svetlana
AU  - Garcia-Fumero, Ricardo
AU  - Exposito-Ruiz, Manuela
AU  - Pasquau-Liaño, Juan
AU  - Jimenez-Morales, Alberto
AU  - Hidalgo-Tenorio, Carmen
PY  - 2022
DO  - 10.1038/s41598-022-19626-2
UR  - http://hdl.handle.net/10668/19626
T2  - Scientific reports
AB  - Colistimethate sodium (CMS) is the inactive prodrug of colistin, CMS has a narrow antibacterial spectrum with concentration-dependent bactericidal activity against multidrug-resistant gram-negative bacteria, including Pseudomonas aeruginosa and...
LA  - en
PB  - Nature Publishing Group
KW  - Bacterial infection
KW  - Antimicrobial resistance
KW  - Antibiotics
KW  - Colistin
KW  - Creatinine
KW  - Gram-Negative Bacterial Infections
KW  - Humans
KW  - Incidence
KW  - Pseudomonas aeruginosa
KW  - Renal Insufficiency
KW  - Retrospective Studies
TI  - Incidence of nephrotoxicity associated with intravenous colistimethate sodium administration for the treatment of multidrug-resistant gram-negative bacterial infections.
TY  - research article
VL  - 12
ER  -